CHA Medical Group and CHA University have opened discussions with Johns Hopkins Medicine International to explore potential joint research and academic exchange programs, the Korean healthcare group said.

The two sides convened at the CHA Bio Complex on April 25, with talks focusing on collaborations in high-impact fields such as stem cell and organoid research. Johns Hopkins Medicine, widely regarded as a world leader in these areas, has pioneered technologies including the creation of midbrain-like organoids from stem cells.

Johns Hopkins Medicine International serves as the global ambassador for Johns Hopkins Medicine, an academic health system that integrates research, clinical care, and education. Johns Hopkins is home to 29 Nobel laureates and is internationally recognized for breakthroughs in regenerative medicine and biomedical sciences.

The two institutions discussed several areas for future collaboration, including promoting joint research, sharing data and technologies, expanding faculty and student exchange programs, developing educational initiatives, and hosting joint academic activities and seminars.

“It is a great honor to have this conversation with Johns Hopkins Medicine International, which continues to inspire hospitals worldwide through its research and management practices,” a CHA official said. “By focusing on cutting-edge areas such as stem cells and organoids, we aim to achieve meaningful advancements in medicine through both domestic and global collaborations.”